• News
  • SAN DIEGO
  • BioTech

Santaris Pharma enters agreement with BetaIsarna Therapeutics

Santaris Pharma A/S and its partner BetaIsarna Therapeutics GmbH have signed an agreement whereby BetaIsarna gains access to certain Santaris technology to further develop its next generation product candidates.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!